Standard
The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies : Efficacy across multiple COPD endpoints over time. / Lipson, David A.; Criner, Gerard; Dransfield, Mark; Halpin, David; Han, Meilan; Jones, C. Elaine; Kilbride, Sally; Lange, Peter; Lomas, David; Martinez, Fernando; Quasny, Holly; Singh, David; Wise, Robert.
In:
European Respiratory Journal, Vol. 54, No. Supplement 63, PA2482, 2019.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
Lipson, DA, Criner, G, Dransfield, M, Halpin, D, Han, M, Jones, CE, Kilbride, S
, Lange, P, Lomas, D, Martinez, F, Quasny, H, Singh, D & Wise, R 2019, '
The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies: Efficacy across multiple COPD endpoints over time',
European Respiratory Journal, vol. 54, no. Supplement 63, PA2482.
https://doi.org/10.1183/13993003.congress-2019.PA2482APA
Lipson, D. A., Criner, G., Dransfield, M., Halpin, D., Han, M., Jones, C. E., Kilbride, S.
, Lange, P., Lomas, D., Martinez, F., Quasny, H., Singh, D., & Wise, R. (2019).
The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies: Efficacy across multiple COPD endpoints over time.
European Respiratory Journal,
54(Supplement 63), [PA2482].
https://doi.org/10.1183/13993003.congress-2019.PA2482Vancouver
Lipson DA, Criner G, Dransfield M, Halpin D, Han M, Jones CE et al.
The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies: Efficacy across multiple COPD endpoints over time.
European Respiratory Journal. 2019;54(Supplement 63). PA2482.
https://doi.org/10.1183/13993003.congress-2019.PA2482Author
Lipson, David A. ; Criner, Gerard ; Dransfield, Mark ; Halpin, David ; Han, Meilan ; Jones, C. Elaine ; Kilbride, Sally ; Lange, Peter ; Lomas, David ; Martinez, Fernando ; Quasny, Holly ; Singh, David ; Wise, Robert. / The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies : Efficacy across multiple COPD endpoints over time. In: European Respiratory Journal. 2019 ; Vol. 54, No. Supplement 63.
Bibtex
@article{37e727da0cfa41039d9974669f9c2d5c,
title = "The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies: Efficacy across multiple COPD endpoints over time",
keywords = "COPD - management",
author = "Lipson, {David A.} and Gerard Criner and Mark Dransfield and David Halpin and Meilan Han and Jones, {C. Elaine} and Sally Kilbride and Peter Lange and David Lomas and Fernando Martinez and Holly Quasny and David Singh and Robert Wise",
year = "2019",
doi = "10.1183/13993003.congress-2019.PA2482",
language = "English",
volume = "54",
journal = "The European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "Supplement 63",
}
RIS
TY - ABST
T1 - The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies
T2 - Efficacy across multiple COPD endpoints over time
AU - Lipson, David A.
AU - Criner, Gerard
AU - Dransfield, Mark
AU - Halpin, David
AU - Han, Meilan
AU - Jones, C. Elaine
AU - Kilbride, Sally
AU - Lange, Peter
AU - Lomas, David
AU - Martinez, Fernando
AU - Quasny, Holly
AU - Singh, David
AU - Wise, Robert
PY - 2019
Y1 - 2019
KW - COPD - management
U2 - 10.1183/13993003.congress-2019.PA2482
DO - 10.1183/13993003.congress-2019.PA2482
M3 - Conference abstract in journal
VL - 54
JO - The European Respiratory Journal
JF - The European Respiratory Journal
SN - 0903-1936
IS - Supplement 63
M1 - PA2482
ER -
